Page last updated: 2024-10-29

ifosfamide and Hypokalemia

ifosfamide has been researched along with Hypokalemia in 3 studies

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Eighteen consecutive cases of encephalopathy occurring after ifosfamide/mesna chemotherapy were prospectively assessed."1.28Ifosfamide encephalopathy: a reappraisal. ( Green, JA; Husband, DJ; Warenius, HM; Watkin, SW, 1989)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Krupadev, V1
Thomas, V1
Dahr, SE1
Warrier, R1
Watkin, SW2
Husband, DJ2
Green, JA1
Warenius, HM1

Other Studies

3 other studies available for ifosfamide and Hypokalemia

ArticleYear
Developmental Delay and Refusal to Walk in an Infant.
    Clinical pediatrics, 2021, Volume: 60, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Developmental Disabilities; Diagnosis, Differen

2021
Ifosfamide encephalopathy: a reappraisal.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:9

    Topics: Adult; Aged; Brain Diseases; Confusion; Female; Humans; Hypokalemia; Ifosfamide; Male; Middle Aged;

1989
Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
    Lancet (London, England), 1988, May-14, Volume: 1, Issue:8594

    Topics: Drug Therapy, Combination; Humans; Hypokalemia; Ifosfamide; Male; Mercaptoethanol; Mesna

1988